Skip to main content
Celon Pharma S.A. logo

Celon Pharma S.A. — Investor Relations & Filings

Ticker · CLN ISIN · PLCLNPH00015 LEI · 259400Q0ERJT0NC5DT24 WAR Manufacturing
Open in API
Filings indexed 709 across all filing types
Latest filing 2018-06-29 Declaration of Voting R…
Country PL Poland
Listing WAR CLN

About Celon Pharma S.A.

https://celonpharma.com/en/

Celon Pharma S.A. is an integrated pharmaceutical company that conducts advanced research and manufactures modern drugs. The company is engaged in the development, production, distribution, and marketing of therapeutic solutions. Its primary focus is on developing treatments for cancers, neurological diseases, diabetes, and other metabolic disorders. As a marketing authorization holder, Celon Pharma manages the full product lifecycle, from scientific research and development to commercialization, aiming to improve patient health and quality of life.

Recent filings

Filing Released Lang Actions
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Walnym Zgromadzeniu GLG Pharma S.A. w dniu 29 czerwca 2018 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document text is very short (298 characters) and explicitly states that the management ('Zarząd GLX Pharma S.A.') is submitting an attachment ('przekazuje w załączeniu do niniejszego raportu') containing a list of shareholders who held at least 5% of the votes at the Annual General Meeting ('Zwyczajnym Walnym Zgromadzeniu Spółki') held on June 29, 2018. This structure—a brief announcement stating that the actual information (shareholder list/voting results) is attached or included—strongly suggests this is an announcement about the publication of results or information related to a general meeting, rather than the full report itself. Since the content relates directly to the results of a shareholder vote at a General Meeting, the most specific category is Declaration of Voting Results & Voting Rights Announcements (DVA). However, given the 'MENU VS MEAL' rule, if this is just a brief notice stating the results are attached, it could also be a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since DVA is a specific category for voting results, and this document explicitly mentions the results from the AGM, DVA is the best fit, assuming the attached document contains the required voting outcome details. If the document were longer and contained the full results, DVA would be certain. Given the brevity and the reference to the AGM results, DVA is prioritized over RPA/RNS.
2018-06-29 Polish
Złożenie wniosku o zgodę na rozpoczęcie II fazy klinicznej badań nad lekiem opartym na Esketaminie - Content (PL)
Regulatory Filings Classification · 95% confidence The document text discusses the submission of an application to the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (Urząd Rejestracji Produktów Leczniczych Wyrobów Medycznych i Produktów Biobójczych) to commence Phase II clinical trials for a drug based on Esketamine. It details the scope, duration, patient numbers, and funding for this development program. This content relates to the ongoing development and regulatory steps for a product, which falls under general corporate updates regarding operations and regulatory progress. Since it is not a formal financial report (10-K, IR, ER), a management discussion (MDA), or a specific legal/governance filing, it best fits the general 'Regulatory Filings' category (RNS) as a significant operational update that doesn't match the more specific codes like CAP, LTR, or DIV. Given the context of a Polish company updating on clinical trial progress, RNS is the most appropriate fallback for a non-standard regulatory/operational announcement.
2018-06-20 Polish
Okazanie weksla. - Content (PL)
Legal Proceedings Report Classification · 95% confidence The document text is very short (648 characters) and discusses a specific legal/financial event: the presentation of a promissory note (weksel) for payment and the company's intention to use legal means to protect its interests against the claim. This relates to a legal dispute or a significant financial obligation being called in. It references a previous 'raport bieżący' (current report). Since it details an ongoing legal/financial conflict and the company's response, it fits best under 'Legal Proceedings Report' (LTR) or potentially a general 'Regulatory Filing' (RNS) if the legal matter isn't the primary focus. Given the context of a dispute over a promissory note and the intent to use legal means, LTR is the most specific fit, as it concerns significant legal matters involving the company.
2018-06-19 Polish
Rejestracja leku Salmex na rynku w Hondurasie - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is a short announcement from the Management Board of Celon Pharma S.A. regarding the registration of a drug (Salmex, trade name Ventiflu Discus) in Honduras via a business partner. It discusses market expansion strategy and potential commercialization. This type of announcement, detailing specific business development or regulatory milestones outside of standard financial reporting (like earnings or annual reports), fits best under the general 'Regulatory Filings' category (RNS) as it is a specific, non-standard corporate disclosure, or potentially a general announcement that doesn't fit the highly specific categories like DIRS, DIV, or CAP. Given the nature of reporting a specific regulatory/market approval event, RNS is the most appropriate fallback.
2018-06-18 Polish
Żądanie umieszczenia spraw w porządku obrad ZWZ
AGM Information Classification · 98% confidence The document text contains multiple resolutions ('Uchwała Nr') passed by the 'Zwyczajne Walne Zgromadzenie' (Annual General Meeting - AGM) of GLG PHARMA S.A. on June 29, 2018. The resolutions concern the composition and remuneration of the Supervisory Board ('Rada Nadzorcza'). The initial part of the document is a formal request from a shareholder (Apollo Capital LLC) to include specific items on the agenda for this AGM, including changes to the Supervisory Board. Since the document contains the actual resolutions passed at the AGM regarding board structure and governance, it is directly related to the meeting proceedings. This aligns best with the 'AGM Information' category (AGM-R), which covers presentations and materials shared during the AGM, including the resulting resolutions.
2018-06-07 Polish
Wniosek Akcjonariusza o rozszerzenie porządku obrad oraz zgłoszenie projektów uchwał na Zwyczajne Walne Zgromadzenie Spółki zwołane na dzień 29 czerwca 2018 r. - Content (PL)
AGM Information Classification · 98% confidence The document text is a formal announcement in Polish regarding an upcoming 'Zwyczajnego Walnego Zgromadzenia Spółki' (Ordinary General Meeting of Shareholders). It details a shareholder's request to include specific items in the agenda, such as detailed financial information and explanations for failing to meet a commitment regarding listing shares. It then presents the updated agenda, which includes standard AGM items (approving reports, granting discharge) alongside the shareholder-requested items. The final paragraph states that the Management Board is attaching the shareholder's request and proposed resolutions ('W załączeniu Zarząd Spółki przekazuje zgłoszone przez Akcjonariusza żądanie oraz projekty uchwał'). Since this document is an announcement about the agenda and related materials for an AGM, and it explicitly mentions attaching the request/proposals, it fits the description of materials shared during the Annual General Meeting (AGM-R). It is not the final voting results (DVA) nor a general proxy solicitation (PSI), but rather the preparatory material/announcement concerning the meeting itself.
2018-06-07 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.